Nature

Modeling the persistence of 4CMenB vaccine protection against real world meningococcal B disease in adolescents

The efficacy of the four-component 4CMenB vaccine is measured through the serum bactericidal antibody (SBA) assay on four meningococcal B (MenB) indicator strains. However, they are not ...
Nature

Modeling gonorrhea vaccination to find optimal targeting strategies that balance impact with cost-effectiveness

Vaccination for UK men who have sex with men (MSM) at increased gonorrhea risk has been advised, but not yet implemented. Effective targeting is essential for cost-effectiveness, but ...
Medscape

One-Dose HPV Vaccine Program Would Be Efficient in Canada

In Canada, switching to a one-dose, gender-neutral vaccination program for human papillomavirus (HPV) could use vaccine doses more efficiently and prevent a similar number of cervical cancer cases, ...
Nasdaq

Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus

Initial computational analysis demonstrated that Evaxion’s AI-Immunology™ platform can identify novel vaccine targets to combat Group A Streptococcus (GAS) New vaccine program is added to Evaxion’s ...

Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line–Derived MVA Vaccine Candidate (TG MVA(TM)) at WCID 2026

TG-MVATM uses a scalable cell line manufacturing process intended to strengthen and diversify global mpox and smallpox vaccine supplyTG-MVATM ...

The HPV vaccine works—but only if we keep trusting it

Human papillomavirus (HPV) vaccination is already saving lives in the UK—and the scale of that success is striking.
Nasdaq

Evaxion A/S Launches EVX-B4 Vaccine Development Program Targeting Group A Streptococcus Infections

Evaxion A/S has announced the initiation of a new vaccine program, EVX-B4, targeting Group A Streptococcus (GAS), a pathogen responsible for a wide range of infections globally, including severe ...